GPCR
Price
$84.33
Change
+$6.41 (+8.23%)
Updated
Jan 14 closing price
Capitalization
5.94B
70 days until earnings call
Intraday BUY SELL Signals
NRIX
Price
$19.03
Change
+$0.10 (+0.53%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
1.93B
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GPCR vs NRIX

Header iconGPCR vs NRIX Comparison
Open Charts GPCR vs NRIXBanner chart's image
Structure Therapeutics
Price$84.33
Change+$6.41 (+8.23%)
Volume$1.79M
Capitalization5.94B
Nurix Therapeutics
Price$19.03
Change+$0.10 (+0.53%)
Volume$91.92K
Capitalization1.93B
GPCR vs NRIX Comparison Chart in %
GPCR
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GPCR vs. NRIX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GPCR is a Hold and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (GPCR: $84.33 vs. NRIX: $19.04)
Brand notoriety: GPCR and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GPCR: 98% vs. NRIX: 59%
Market capitalization -- GPCR: $5.94B vs. NRIX: $1.93B
GPCR [@Biotechnology] is valued at $5.94B. NRIX’s [@Biotechnology] market capitalization is $1.93B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GPCR’s FA Score shows that 0 FA rating(s) are green whileNRIX’s FA Score has 0 green FA rating(s).

  • GPCR’s FA Score: 0 green, 5 red.
  • NRIX’s FA Score: 0 green, 5 red.
According to our system of comparison, both GPCR and NRIX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GPCR’s TA Score shows that 3 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • GPCR’s TA Score: 3 bullish, 4 bearish.
  • NRIX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than GPCR.

Price Growth

GPCR (@Biotechnology) experienced а +27.29% price change this week, while NRIX (@Biotechnology) price change was +2.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

GPCR is expected to report earnings on Mar 26, 2026.

NRIX is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GPCR($5.94B) has a higher market cap than NRIX($1.93B). GPCR YTD gains are higher at: 21.251 vs. NRIX (-0.211). GPCR (-246.42M) and NRIX (-248.7M) have comparable annual earnings (EBITDA) . GPCR has more cash in the bank: 799M vs. NRIX (429M). GPCR has less debt than NRIX: GPCR (7.09M) vs NRIX (56.5M). NRIX has higher revenues than GPCR: NRIX (83.7M) vs GPCR (0).
GPCRNRIXGPCR / NRIX
Capitalization5.94B1.93B308%
EBITDA-246.42M-248.7M99%
Gain YTD21.251-0.211-10,078%
P/E RatioN/AN/A-
Revenue083.7M-
Total Cash799M429M186%
Total Debt7.09M56.5M13%
TECHNICAL ANALYSIS
Technical Analysis
GPCRNRIX
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
87%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
GPCR
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LBGAX42.710.01
+0.02%
ClearBridge Mid Cap Growth A
EIUTX16.14-0.02
-0.12%
Eaton Vance Dividend Builder I
PGODX82.64-0.29
-0.35%
Putnam Large Cap Growth R5
AIVEX20.96-0.09
-0.43%
American Funds International Vntg F-1
OBGIX33.39-0.17
-0.51%
Oberweis Global Opportunities Instl

GPCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, GPCR has been closely correlated with WVE. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GPCR jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GPCR
1D Price
Change %
GPCR100%
+8.23%
WVE - GPCR
69%
Closely correlated
+2.04%
KYMR - GPCR
50%
Loosely correlated
+1.46%
FULC - GPCR
49%
Loosely correlated
+1.07%
OCUL - GPCR
47%
Loosely correlated
+6.14%
NRIX - GPCR
43%
Loosely correlated
+0.58%
More

NRIX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRIX has been loosely correlated with KYMR. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if NRIX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRIX
1D Price
Change %
NRIX100%
+2.99%
KYMR - NRIX
65%
Loosely correlated
+1.42%
KURA - NRIX
55%
Loosely correlated
+0.44%
XNCR - NRIX
55%
Loosely correlated
-1.62%
OCUL - NRIX
54%
Loosely correlated
-2.43%
TYRA - NRIX
53%
Loosely correlated
+0.14%
More